Effectiveness of Saccharomyces boulardii in a rat model of colitis

doi:10.3748/wjg.v18.i44.6452

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3960)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

371

HTML

3164

Figures (1-2)

211

Tables (1-3)

214

Sum=3960

Nov 28, 2012 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 28, 2012; 18(44): 6452-6460
Published online Nov 28, 2012. doi: 10.3748/wjg.v18.i44.6452

Full Size Figure Download Figure

Figure 2 Serum and tissue nitric oxide and tumor necrosis factor-α levels of the experimental groups. A: Serum and tissue nitric oxide levels; B: Serum and tissue tumor necrosis factor (TNF)-α levels. The results are shown as the mean ± SD. ^aP < 0.05 vs Saccharomyces boulardii (S. boulardii) + methyl prednisolone (MP); ^cP < 0.05 vs trinitrobenzene sulfonic acid (TNBS). NO: Nitric oxide.

Citation: Soyturk M, Saygili SM, Baskin H, Sagol O, Yilmaz O, Saygili F, Akpinar H. Effectiveness of Saccharomyces boulardii in a rat model of colitis. World J Gastroenterol 2012; 18(44): 6452-6460
URL: https://www.wjgnet.com/1007-9327/full/v18/i44/6452.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i44.6452